XNAS 15 Sep, 2026 11:02 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Oliver Dolan | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 13.51 per share. | 08 Sep 2026 | 7,347 | 16,252 | - | 13.5 | 99,286 | Common Stock |
| Oliver Dolan | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 13.67 per share. | 08 Sep 2026 | 6 | 16,246 | - | 13.7 | 82 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 13.96 per share. | 26 Aug 2026 | 249 | 680,948 | - | 14.0 | 3,476 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 13.96 per share. | 26 Aug 2026 | 51 | 141,002 | - | 14.0 | 712 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 19 Aug 2026 | 23,584 | 681,197 | - | 14 | 330,176 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 19 Aug 2026 | 4,884 | 141,053 | - | 14 | 68,376 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 13.96 per share. | 11 Aug 2026 | 1,775 | 704,781 | - | 14.0 | 24,779 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 13.96 per share. | 11 Aug 2026 | 368 | 145,937 | - | 14.0 | 5,137 | Common Stock |
| Ram Aiyar | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.84 per share. | 04 Aug 2026 | 5,802 | 69,046 | - | 10.8 | 62,917 | Common Stock |
| Loic A Vincent | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2026 | 7,500 | 25,797 | - | 0 | Common Stock | |
| Todd Chappell | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2026 | 7,500 | 24,464 | - | 0 | Common Stock | |
| Jeffrey Cerio | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2026 | 6,500 | 41,793 | - | 0 | Common Stock | |
| Oliver Dolan | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2026 | 5,500 | 23,599 | - | 0 | Common Stock | |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 14.03 per share. | 02 Jul 2026 | 14,745 | 154,811 | - | 14.0 | 206,872 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 13.96 per share. | 02 Jul 2026 | 817 | 706,556 | - | 14.0 | 11,405 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 13.96 per share. | 02 Jul 2026 | 8,506 | 146,305 | - | 14.0 | 118,744 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 14.03 per share. | 02 Jul 2026 | 85,955 | 707,373 | - | 14.0 | 1,205,949 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 14.60 per share. | 22 Jun 2026 | 6,979 | 169,670 | - | 14.6 | 101,893 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 13.95 per share. | 22 Jun 2026 | 3,382 | 936,252 | - | 14.0 | 47,179 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 14.98 per share. | 22 Jun 2026 | 114 | 169,556 | - | 15.0 | 1,708 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 14.98 per share. | 22 Jun 2026 | 666 | 793,328 | - | 15.0 | 9,977 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 14.25 per share. | 22 Jun 2026 | 17,426 | 176,649 | - | 14.3 | 248,321 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 14.25 per share. | 22 Jun 2026 | 101,579 | 834,673 | - | 14.3 | 1,447,501 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 13.95 per share. | 22 Jun 2026 | 580 | 194,075 | - | 14.0 | 8,091 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 14.60 per share. | 22 Jun 2026 | 40,679 | 793,994 | - | 14.6 | 593,913 | Common Stock |
| Loic A Vincent | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.83 per share. | 16 Jun 2026 | 3,418 | 18,297 | - | 10.8 | 37,017 | Common Stock |
| Oliver Dolan | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 10.83 per share. | 16 Jun 2026 | 3,383 | 18,099 | - | 10.8 | 36,638 | Common Stock |
| Jeffrey Cerio | General Counsel | Sale of securities on an exchange or to another person at price $ 10.83 per share. | 16 Jun 2026 | 6,609 | 35,293 | - | 10.8 | 71,575 | Common Stock |
| Todd Chappell | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.83 per share. | 16 Jun 2026 | 3,168 | 16,964 | - | 10.8 | 34,309 | Common Stock |
| Timothy R. Pearson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 14,677 | 14,677 | - | - | Stock Option (Right to Buy) | |
| Jean-Francois Formela | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 14,677 | 14,677 | - | - | Stock Option (Right to Buy) | |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 14,677 | 14,677 | - | - | Stock Option (Right to Buy) | |
| Nessan Bermingham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 14,677 | 14,677 | - | - | Stock Option (Right to Buy) | |
| Katharine Knobil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 14,677 | 14,677 | - | - | Stock Option (Right to Buy) | |
| Rachel Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 14,677 | 14,677 | - | - | Stock Option (Right to Buy) | |
| Ram Aiyar | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.98 per share. | 29 May 2026 | 15,152 | 74,848 | - | 13.0 | 196,673 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 13.95 per share. | 28 May 2026 | 2,441 | 939,634 | - | 14.0 | 34,052 | Common Stock |
| Jean-Francois Formela | Director | Sale of securities on an exchange or to another person at price $ 13.95 per share. | 28 May 2026 | 419 | 194,655 | - | 13.9 | 5,845 | Common Stock |
| Ram Aiyar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 12.33 per share. | 26 May 2026 | 50,000 | 90,000 | - | 12.3 | 616,500 | Common Stock |
| Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 242,945 | 242,945 | - | - | Pre-Funded Warrants | |
| Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 11.11 per share. | 10 Mar 2026 | 207,100 | 1,297,893 | - | 11.1 | 2,300,881 | Common Stock |
| Ram Aiyar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Loic A Vincent | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Oliver Dolan | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Cerio | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 23,000 | 23,000 | - | - | Stock Option (Right to Buy) | |
| Todd Chappell | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
| Ram Aiyar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 40,000 | 40,000 | - | 0 | Common Stock | |
| Loic A Vincent | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2025 | 21,715 | 21,715 | - | 0 | Common Stock | |
| Oliver Dolan | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2025 | 21,482 | 21,482 | - | 0 | Common Stock | |
| Jeffrey Cerio | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2025 | 41,902 | 41,902 | - | 0 | Common Stock | |
| Todd Chappell | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2025 | 20,132 | 20,132 | - | 0 | Common Stock | |
| Rachel Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,010 | 6,010 | - | - | Stock Option (Right to Buy) | |
| Katharine Knobil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,010 | 6,010 | - | - | Stock Option (Right to Buy) | |
| Nessan Bermingham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,010 | 6,010 | - | - | Stock Option (Right to Buy) | |
| Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,010 | 6,010 | - | - | Stock Option (Right to Buy) | |
| Timothy R. Pearson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,010 | 6,010 | - | - | Stock Option (Right to Buy) | |
| Jean-Francois Formela | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,010 | 6,010 | - | - | Stock Option (Right to Buy) | |
| Loic A Vincent | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Oliver Dolan | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Olukemi Olugemo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 42,000 | 42,000 | - | - | Stock Option (Right to Buy) | |
| Ram Aiyar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Vineet Agarwal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Todd Chappell | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 34,500 | 34,500 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Cerio | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 29,000 | 29,000 | - | - | Stock Option (Right to Buy) | |
| Vineet Agarwal | Chief Financial Officer | 11 Nov 2024 | 800 | 0 | - | 70 | 56,000 | Common Stock | |
| Vineet Agarwal | Chief Financial Officer | 11 Nov 2024 | 800 | 30,807 | - | - | Stock Option (Right to Buy) | ||
| Vineet Agarwal | Chief Financial Officer | 11 Nov 2024 | 800 | 800 | - | 11.7 | 9,344 | Common Stock | |
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 9,263 | 31,607 | - | - | Stock Option (Right to Buy) | ||
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 953 | 45,594 | - | - | Stock Option (Right to Buy) | ||
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 2,023 | 8,193 | - | 71.5 | 144,663 | Common Stock | |
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 164 | 8,029 | - | 73.7 | 12,089 | Common Stock | |
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 115 | 7,914 | - | 74.6 | 8,575 | Common Stock | |
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 56 | 7,858 | - | 76 | 4,256 | Common Stock | |
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 23 | 7,835 | - | 77 | 1,771 | Common Stock | |
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 260 | 7,575 | - | 77.6 | 20,164 | Common Stock | |
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 1,815 | 5,303 | - | 79.8 | 144,821 | Common Stock | |
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 4,961 | 342 | - | 80.5 | 399,374 | Common Stock | |
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 317 | 25 | - | 81.5 | 25,829 | Common Stock | |
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 25 | 0 | - | 82.9 | 2,072 | Common Stock | |
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 457 | 7,118 | - | 78.6 | 35,914 | Common Stock | |
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 9,263 | 9,263 | - | 11.7 | 108,192 | Common Stock | |
| Vineet Agarwal | Chief Financial Officer | 17 Oct 2024 | 953 | 10,216 | - | 15.0 | 14,276 | Common Stock | |
| Jeffrey Cerio | General Counsel | 03 Sep 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | ||
| Katharine Knobil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 9,041 | 9,041 | - | - | Stock Option (Right to Buy) | |
| Rachel Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 5,190 | 5,190 | - | - | Stock Option (Right to Buy) | |
| David L. Lucchino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 5,190 | 5,190 | - | - | Stock Option (Right to Buy) | |
| Nessan Bermingham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 5,190 | 5,190 | - | - | Stock Option (Right to Buy) | |
| Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 5,190 | 5,190 | - | - | Stock Option (Right to Buy) | |
| Timothy R. Pearson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 5,190 | 5,190 | - | - | Stock Option (Right to Buy) | |
| Jean-Francois Formela | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 5,190 | 5,190 | - | - | Stock Option (Right to Buy) | |
| Olukemi Olugemo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Jean-Francois Formela | Director | Grant, award, or other acquisition of securities at price $ 56.00 per share. | 22 Apr 2024 | 17,857 | 195,074 | - | 56 | 999,992 | Common Stock |
| Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 56.00 per share. | 22 Apr 2024 | 17,857 | 1,090,793 | - | 56 | 999,992 | Common Stock |